Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Mar2024]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Revenues ₹11,983 Cr ₹12,381 Cr ₹12,192 Cr ₹11,941 Cr ₹10,931 Cr ₹11,241 Cr ₹10,952 Cr ₹10,762 Cr
Expenses ₹8,948 Cr ₹9,028 Cr ₹9,013 Cr ₹8,611 Cr ₹8,129 Cr ₹8,237 Cr ₹7,996 Cr ₹8,023 Cr
Operating Income ₹3,035 Cr ₹3,352 Cr ₹3,179 Cr ₹3,330 Cr ₹2,802 Cr ₹3,004 Cr ₹2,957 Cr ₹2,739 Cr
Other Income ₹606 Cr ₹375 Cr ₹294 Cr ₹206 Cr ₹373 Cr ₹174 Cr ₹85 Cr ₹148 Cr
Interest ₹74 Cr ₹35 Cr ₹49 Cr ₹81 Cr ₹93 Cr ₹46 Cr ₹19 Cr ₹14 Cr
Depreciation ₹650 Cr ₹622 Cr ₹633 Cr ₹651 Cr ₹672 Cr ₹660 Cr ₹610 Cr ₹588 Cr
Profit Before Tax ₹2,816 Cr ₹3,000 Cr ₹2,791 Cr ₹2,481 Cr ₹2,240 Cr ₹2,471 Cr ₹2,412 Cr ₹2,285 Cr
Profit After Tax ₹2,667 Cr ₹2,568 Cr ₹2,401 Cr ₹2,013 Cr ₹2,017 Cr ₹2,188 Cr ₹2,260 Cr ₹2,096 Cr
EPS ₹11.06 ₹10.52 ₹9.90 ₹8.43 ₹8.27 ₹9.03 ₹9.43 ₹8.59
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -0% 5% 47.2%
CIPLA 0.3% -1.8% 47.2%
DR REDDYS LABORATORIES 3.2% 11.5% 30.2%
ZYDUS LIFESCIENCES 1.9% 9% 100.9%
DIVIS LABORATORIES 0.5% -0.4% 24.7%
MANKIND PHARMA 2.1% -4.1% 24.2%
TORRENT PHARMACEUTICALS 0.5% 2.7% 52%
LUPIN 1.1% 14.1% 96.9%
AUROBINDO PHARMA 3.1% 9.5% 80.3%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

-3.21 %

Y-o-Y

9.63 %

Quarters Revenues % Change
Mar2024 ₹11,983 Cr
-3.21
Dec2023 ₹12,381 Cr
1.54
Sep2023 ₹12,192 Cr
2.11
Jun2023 ₹11,941 Cr
9.24
Mar2023 ₹10,931 Cr
-2.76
Dec2022 ₹11,241 Cr
2.64
Sep2022 ₹10,952 Cr
1.77
Jun2022 ₹10,762 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-9.46 %

Y-o-Y

8.32 %

Quarters Operating Profit % Change
Mar2024 ₹3,035 Cr
-9.46
Dec2023 ₹3,352 Cr
5.44
Sep2023 ₹3,179 Cr
-4.52
Jun2023 ₹3,330 Cr
18.83
Mar2023 ₹2,802 Cr
-6.71
Dec2022 ₹3,004 Cr
1.60
Sep2022 ₹2,957 Cr
7.95
Jun2022 ₹2,739 Cr -
Operating Margins
Q-o-Q

-6.46 %

Y-o-Y

-1.21 %

Quarters Operating Margin% % Change
Mar2024 25.33%
-6.46
Dec2023 27.08%
3.83
Sep2023 26.08%
-6.49
Jun2023 27.89%
8.78
Mar2023 25.64%
-4.04
Dec2022 26.72%
-1.00
Sep2022 26.99%
6.05
Jun2022 25.45% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

3.84 %

Y-o-Y

32.22 %

Quarters Profit After Tax % Change
Mar2024 ₹2,667 Cr
3.84
Dec2023 ₹2,568 Cr
6.97
Sep2023 ₹2,401 Cr
19.26
Jun2023 ₹2,013 Cr
-0.19
Mar2023 ₹2,017 Cr
-7.83
Dec2022 ₹2,188 Cr
-3.19
Sep2022 ₹2,260 Cr
7.84
Jun2022 ₹2,096 Cr -
PAT Margins
Q-o-Q

7.28 %

Y-o-Y

20.60 %

Quarters PAT Margin(%) % Change
Mar2024 22.25 %
7.28
Dec2023 20.74 %
5.33
Sep2023 19.69 %
16.79
Jun2023 16.86 %
-8.62
Mar2023 18.45 %
-5.19
Dec2022 19.46 %
-5.72
Sep2022 20.64 %
6.01
Jun2022 19.47 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

5.13 %

Y-o-Y

33.74 %

Quarters EPS % Change
Mar2024 ₹11.06
5.13
Dec2023 ₹10.52
6.26
Sep2023 ₹9.9
17.44
Jun2023 ₹8.43
1.93
Mar2023 ₹8.27
-8.42
Dec2022 ₹9.03
-4.24
Sep2022 ₹9.43
9.78
Jun2022 ₹8.59 -

You may also like the below Video Courses